SCHEMBL4850158

SCHEMBL4850158

Cc1cccc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccccc3CN(C)C)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 6/20 0.41
ESR1 P03372 2/20 0.40
HRH1 P35367 1/20 0.40
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGER1 P34995 2/20 0.38
PTGER4 P35408 2/20 0.38
PTGER3 P43115 2/20 0.38
PTGER2 P43116 2/20 0.38
BCHE P06276 2/20 0.38
ACHE P22303 2/20 0.38
MCHR1 Q99705 1/20 0.38
GAA P10253 1/20 0.37
ESR2 Q92731 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
KIT P10721 1/20 0.36
KDR P35968 1/20 0.36
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852988 0.93 HRH1 (0.41) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4854570 0.92 HRH1 (0.41) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4852994 0.90 PTGER1 (0.45) HRH1KDM4EALDH1A1SMN1; SMN2PTGER1
SCHEMBL4852871 0.90 SLC6A9 (0.45) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4850155 0.90 SLC6A9 (0.45) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4847882 0.88 HRH1 (0.39) ESR1HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4848480 0.87 ESR1 (0.39) ESR1HRH1KDM4EALDH1A1BCHE
SCHEMBL4847450 0.87 SLC6A9 (0.43) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4847768 0.86 MKNK1 (0.41) SLC6A9ESR1HRH1KDM4EALDH1A1
SCHEMBL4853004 0.86 HRH3 (0.40) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed